GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novacyt ALNOV.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.42

+2.93%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Novacyt — daily ALNOV

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Novacyt on TradingView ↗
Market value
€29.8m
Last close × shares
Volume
77.1k
Shares, 9 Nov 2026

About Novacyt

Its shares trade on Euronext Paris under the ticker ALNOV.PA. It has been listed since 12 October 2012. In the fiscal year to 31 December 2025, it reported revenue of £20.4m and a net loss of £23.3m. At that date it held total assets of £40.3m and shareholders' equity of £23.3m.

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The firm provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The firm creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.

Figures and description from our data supplier, not checked against the company's own report.

More about Novacyt →

Latest on Novacyt

Our reporting

We have not reported on Novacyt yet.

Next results

29 Apr 2027

Due on 29 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Novacyt's ticker?

Novacyt trades as ALNOV.PA on Euronext Paris, under ISIN FR0010397232.

What was Novacyt's last closing price?

0.42 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Novacyt next report results?

Results are expected on 29 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.